Clinical trials referenced in this document:
Funding for this research was provided by:
National Cancer Institute of the National Institutes of Health (P30CA033572)
Celgene (General Research Support)
National Comprehensive Cancer Network (NCCNMIRV0016)
Received: 30 August 2018
Accepted: 2 January 2019
First Online: 8 January 2019
Compliance with ethical standards
: MC receives personal fees from Astra Zeneca and VC is a member of the Celgene Speaker’s Bureau.
: All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.